Financial & Business News
LATEST INVESTING HEADLINES
NEW YORK, NY / ACCESS Newswire / June 2, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Biohaven Ltd. ("Biohaven Ltd.
NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zenas-biopharma-inc-lawsuit-submission-form?prid=151317&wire=1&utm_campaign=13 or contact Joseph E. Levi, Esq.
NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Globus Medical, Inc. (“Globus” or the “Company”) (NYSE: GMED). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Sea's three businesses delivered strong growth in Q1. Garena, in particular, gave investors a huge surprise. At the same time, Sea is driving serious operating leverage — expect earnings to explode for many years to come. Despite being up 350% in 18 months, Sea is still trading at a reasonable valuation.
Grocery store giant Kroger Co (NYSE:KR) has been steadily chopping higher on the charts for almost a year now.
Apple reportedly filed an appeal against an order from the European Union's antitrust regulator that requires the company to make its iOS operating system more compatible with other companies' products. The company filed its appeal Friday (May 30) at the EU's General Court in Luxembourg, The Wall Street Journal (WSJ) reported Monday (June 2).
NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Redwire Corporation (“Redwire” or the “Company”) (NYSE: RDW). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Zuckerberg has said the company aimed to build an AI one-stop shop where businesses can set goals, allocate budgets and let the platform handle the logistics.
HSBC to invest $4 billion in private credit funds as it pivots from traditional lending to higher-margin opportunities.
US growth and value stocks are flat in 2025, but large caps outperform small caps while foreign equities surge. I reiterate a buy rating on SPYV, citing its reasonable valuation, attractive yield, and growing assets despite recent underperformance. SPYV offers exposure to undervalued large-cap US stocks, with a sector tilt away from mega-cap tech toward energy and defensive names.